Centric Health Corp. (TSE:CRX – Free Report) – Research analysts at Ventum Cap Mkts lowered their Q4 2024 earnings per share (EPS) estimates for Centric Health in a note issued to investors on Monday, November 11th. Ventum Cap Mkts analyst S. Quenneville now expects that the company will post earnings per share of ($0.01) for the quarter, down from their prior forecast of $0.01. Ventum Cap Mkts currently has a “Strong-Buy” rating on the stock. Ventum Cap Mkts also issued estimates for Centric Health’s FY2025 earnings at $0.15 EPS.
Separately, Stifel Canada lowered shares of Centric Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 12th.
Centric Health Price Performance
Featured Articles
- Five stocks we like better than Centric Health
- The How And Why of Investing in Oil Stocks
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- NYSE Stocks Give Investors a Variety of Quality Options
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- What is the Australian Securities Exchange (ASX)
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
